CAS 286930-03-8|Fesoterodine Fumarate
| Common Name | Fesoterodine Fumarate | ||
|---|---|---|---|
| CAS Number | 286930-03-8 | Molecular Weight | 527.649 |
| Density | / | Boiling Point | 518.9ºC at 760 mmHg |
| Molecular Formula | C30H41NO7 | Melting Point | 72-78ºC |
| MSDS | / | Flash Point | 267.6ºC |
Names
| Name | (E)-but-2-enedioic acid,[2-[(1R)-3-[di(propan-2-yl)amino]-1-phenylpropyl]-4-(hydroxymethyl)phenyl] 2-methylpropanoate |
|---|---|
| Synonym | More Synonyms |
Fesoterodine Fumarate BiologicalActivity
| Description | Fesoterodine Fumarate is an antimuscarinic agent and is rapidly de-esterified to its active metabolite 5-hydroxymethyl tolterodine that is a muscarinic receptor antagonist.IC50 value:Target: mAChRFesoterodine has the advantage of allowing more flexible dosage than other muscarinic antagonists. Its tolerability and side effects are similar to other muscarinic antagonists and as a new drug seems unlikely to make great changes in practices of treatment for overactive bladder. |
|---|---|
| Related Catalog | Signaling Pathways >>GPCR/G Protein >>mAChRSignaling Pathways >>Neuronal Signaling >>mAChRResearch Areas >>Neurological Disease |
| References | [1]. Staskin David; Khullar Vik; Michel Martin C et al. Effects of voluntary dose escalation in a placebo-controlled, flexible-dose trial of fesoterodine in subjects with overactive bladder. Neurourology and urodynamics (2011), 30(8), 1480-5. [2]. Vella Maria; Cardozo Linda Review of fesoterodine. Expert opinion on drug safety (2011), 10(5), 805-8. [3]. Malhotra Bimal; Alvey Christine; Gong Jason et al. Effects of fesoterodine on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers. British journal of clinical pharmacology (2011), 72(2), 257-62. [4]. Michel MC. Fesoterodine: a novel muscarinic receptor antagonist for the treatment of overactive bladder syndrome. Expert Opin Pharmacother. 2008 Jul;9(10):1787-96. [5]. Fesoterodine |
Chemical & Physical Properties
| Boiling Point | 518.9ºC at 760 mmHg |
|---|---|
| Melting Point | 72-78ºC |
| Molecular Formula | C30H41NO7 |
| Molecular Weight | 527.649 |
| Flash Point | 267.6ºC |
| Exact Mass | 527.288330 |
| PSA | 124.37000 |
| LogP | 5.09290 |
| InChIKey | MWHXMIASLKXGBU-RNCYCKTQSA-N |
| SMILES | CC(C)C(=O)Oc1ccc(CO)cc1C(CCN(C(C)C)C(C)C)c1ccccc1.O=C(O)C=CC(=O)O |
| Storage condition | Hygroscopic, Store under Inert atmosphere -20°C Freezer |
Synonyms
| (R)-Fesoterodine fumarate |
| Fesoterodine Fumarate |
| UNII-EOS72165S7 |
| SPM 8272 |
| SPM 907 |
| Propanoic acid, 2-methyl-, 2-[(1R)-3-[bis(1-methylethyl)amino]-1-phenylpropyl]-4-(hydroxymethyl)phenyl ester, (2E)-2-butenedioate (1:1) |
| Toviaz,Fesoterodine fumarate |
| 2-[(1R)-3-(Diisopropylamino)-1-phenylpropyl]-4-(hydroxymethyl)phenyl 2-methylpropanoate (2E)-2-butenedioate (1:1) |
| Propanoic acid,2-methyl-,2-((1R)-3-(bis(1-methylethyl)amino)-1-phenylpropyl)-4-(hydroxymethyl)phenyl ester,(2E)-2-butenedioate (1:1) (salt) |
| Fesoterodinefumarate |
| Toviaz |
| (R)-2-(3-(Diisopropylamino)-1-phenylpropyl)-4-(hydroxymethyl)phenyl isobutyrate fumarate |
| Fesoterodine (fumarate) |
